| Item | Current | Prior | YoY % |
|---|---|---|---|
| Net Sales | ¥974M | ¥1.32B | -26.2% |
| Cost of Sales | ¥587M | ¥614M | -4.3% |
| Gross Profit | ¥387M | ¥707M | -45.2% |
| SG&A Expenses | ¥934M | ¥856M | +9.1% |
| Operating Income | ¥-546M | ¥-149M | -266.4% |
| Non-operating Income | ¥88M | ¥57M | +52.6% |
| Non-operating Expenses | ¥24M | ¥12M | +112.0% |
| Ordinary Income | ¥-483M | ¥-103M | -368.9% |
| Profit Before Tax | ¥-483M | ¥-103M | -368.1% |
| Income Tax Expense | ¥3M | ¥962,000 | +206.9% |
| Net Income | ¥-486M | ¥-104M | -366.7% |
| Net Income Attributable to Owners | ¥-486M | ¥-104M | -367.3% |
| Total Comprehensive Income | ¥-309M | ¥-249M | -24.1% |
| Depreciation & Amortization | ¥33M | ¥20M | +61.8% |
| Basic EPS | ¥-5.14 | ¥-1.14 | -350.9% |
| Dividend Per Share | ¥0.00 | ¥0.00 | - |
| Item | Current End | Prior End | Change |
|---|---|---|---|
| Current Assets | ¥6.55B | ¥4.90B | +¥1.66B |
| Cash and Deposits | ¥2.64B | ¥2.82B | ¥-188M |
| Accounts Receivable | ¥329M | ¥464M | ¥-135M |
| Inventories | ¥132M | ¥133M | ¥-647,000 |
| Non-current Assets | ¥2.81B | ¥4.77B | ¥-1.96B |
| Item | Current | Prior | Change |
|---|---|---|---|
| Operating Cash Flow | ¥-342M | ¥-131M | ¥-211M |
| Investing Cash Flow | ¥123M | ¥-412M | +¥535M |
| Financing Cash Flow | ¥681M | ¥681M | ¥0 |
| Free Cash Flow | ¥-220M | - | - |
| Item | Value |
|---|---|
| Book Value Per Share | ¥91.62 |
| Net Profit Margin | -49.9% |
| Gross Profit Margin | 39.7% |
| Current Ratio | 1107.0% |
| Quick Ratio | 1084.7% |
| Debt-to-Equity Ratio | 0.08x |
| EBITDA Margin | -52.7% |
| Effective Tax Rate | -0.6% |
| Item | YoY Change |
|---|---|
| Net Sales YoY Change | -26.2% |
| Item | Value |
|---|---|
| Shares Outstanding (incl. Treasury) | 94.80M shares |
| Treasury Stock | 117K shares |
| Average Shares Outstanding | 94.69M shares |
| Book Value Per Share | ¥91.62 |
| EBITDA | ¥-513M |
| Item | Amount |
|---|---|
| Q2 Dividend | ¥0.00 |
| Year-End Dividend | ¥0.00 |
| Segment | Revenue |
|---|---|
| Medical | ¥87M |
| ResearchSupport | ¥887M |
| Item | Forecast |
|---|---|
| Net Sales Forecast | ¥3.04B |
| Operating Income Forecast | ¥-268M |
| Ordinary Income Forecast | ¥-75M |
| Net Income Attributable to Owners Forecast | ¥-75M |
| Basic EPS Forecast | ¥-0.79 |
| Dividend Per Share Forecast | ¥0.00 |
| Property, Plant & Equipment | ¥245M | ¥242M | +¥3M |
| Intangible Assets | ¥23M | ¥27M | ¥-4M |
| Goodwill | ¥8M | ¥8M | +¥225,000 |
| Investment Securities | ¥2.45B | ¥4.40B | ¥-1.95B |
| Total Assets | ¥9.36B | ¥9.67B | ¥-307M |
| Current Liabilities | ¥592M | ¥641M | ¥-49M |
| Accounts Payable | ¥148M | ¥131M | +¥17M |
| Non-current Liabilities | ¥96M | ¥45M | +¥51M |
| Total Liabilities | ¥688M | ¥686M | +¥2M |
| Total Equity | ¥8.68B | ¥8.98B | ¥-309M |
| Capital Stock | ¥2.69B | ¥2.69B | ¥0 |
| Capital Surplus | ¥6.24B | ¥6.24B | ¥0 |
| Retained Earnings | ¥-428M | ¥58M | ¥-486M |
| Treasury Stock | ¥-916,000 | ¥-916,000 | ¥0 |
| Owners' Equity | ¥8.68B | ¥8.98B | ¥-309M |
| Working Capital | ¥5.96B | - | - |